Standard BioTools Inc.LABNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank7
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-100.35%
↓ 63% vs avg
Percentile
P7
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
-61.56%
Historical baseline
PeriodValueYoY Change
TTM-100.35%-48.2%
2024-67.73%-32.2%
2023-51.21%+71.1%
2022-177.21%-422.7%
2021-33.90%-35.3%
2020-25.05%+37.0%
2019-39.76%-44.8%
2018-27.47%+29.4%
2017-38.92%+27.9%
2016-54.02%-